ABEO
Abeona Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.00
+1.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 15.77x
- P/S forward
- 4.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.68x
- Price / sales
- 13.44x
- Price / cash flow
- -4.49x
Enterprise value
- Enterprise value
- $216.2M
- EV / sales
- 8.47x
- EV / EBITDA
- -3.03x
- EV / EBIT
- -2.59x
- Market cap
- $343.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026